Home › Gilead Sciences, Inc. (GILD) Downgraded by Vetr Inc. to "Buy"
 

Keywords :   


Gilead Sciences, Inc. (GILD) Downgraded by Vetr Inc. to "Buy"

2016-04-04 08:36:27| Biotech - Topix.net

They presently have a $104.96 target price on the biopharmaceutical company's stock. Vetr 's target price would suggest a potential upside of 11.52% from the stock's current price.

Tags: to buy sciences downgraded

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
10.05Faisal Islam: Economy is getting better but people may not notice
10.05Sulfate-Free Foamable Solid Cleanser Patented by Johnson & Johnson
10.05Farm Progress America, May 10, 2024
10.05Farm Progress America, May 10, 2024
10.05Comcast releases research on how viewers discover new TV content
10.05Samba TV uses GenAI to provide actionable context for video ads
10.05Roku unveils screensaver ad integrations, ad partnerships and fresh content
10.05Samsung TV Plus partners with MLB, PGA Tour, F1 and ONE Championship
More »